SEC Form 4 · accession 0001127602-15-010888
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Mar 9, 2015
Accepted (ET)
Mar 10, 2015 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 9, 2015 | M | 2,592 | $52.65 | A | 2,832 | D | |
| Common StockF2 | Mar 9, 2015 | S | 200 | $158.64 | D | 2,632 | D | |
| Common StockF3 | Mar 9, 2015 | S | 402 | $159.6014 | D | 2,230 | D | |
| Common StockF5 | Mar 9, 2015 | S | 1,882 | $160.8415 | D | 348 | D | |
| Common StockF6 | Mar 9, 2015 | S | 108 | $161.5144 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 533,094 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $52.65 | Mar 9, 2015 | M | 2,592 | D | Dec 31, 2009 | Dec 31, 2019 | Common Stock | 2,592 | 513,569 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2This transaction was executed in multiple trades at prices ranging from $158.16 to $159.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $159.26 to $160.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F5This transaction was executed in multiple trades at prices ranging from $160.41 to $161.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $161.50 to $161.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.